Acute Migraine Study

Evanston Premier Healthcare Research


Do you have acute migraines?

If so, you may qualify for a randomized, double-blind, single-dose, placebo-controlled study to assess the efficacy and safety of AXS-07 (meloxicam and rizatriptan) for the acute treatment of migraine in adults with inadequate response to prior acute treatments.

You may qualify if:

    You are male or female ages 18 to 65.

    You have a history of episodic migraine for at least 1 year.

    You have 2 to 8 migraine attacks per month.

    Inadequate response to prior acute treatments.

Please fill out the form below and we will contact you.

    Your Name (required)

    Your Email Address (required)
    Your email address will be used exclusively to contact you regarding our studies.

    Your telephone number


    Your Message